Literature DB >> 17041934

Microdeletion and microduplication 22q11.2 screening in 295 patients with clinical features of DiGeorge/Velocardiofacial syndrome.

Anna Brunet1, Elisabeth Gabau, Rosa Maria Perich, Laura Valdesoiro, Carme Brun, Maria Rosa Caballín, Miriam Guitart.   

Abstract

The 22q11.2 region is susceptible to chromosomal rearrangements, leading to various types of congenital malformation and mental retardation. The most common anomaly is 22q11.2 microdeletion, associated with DiGeorge/Velocardiofacial syndrome (DG/VCFS). Recently the microduplication 22q11.2 syndrome has been identified. Some clinical features in patients with this new chromosomal disorder present a substantial overlap with DG/VCFS. The aim of this hospital-based study was to evaluate the incidence of deletions and duplications on 22q11.2 in patients with DG/VCFS features. We investigated a group of 295 patients with widely variable manifestations associated with DG/VCFS. Along with the clinical diagnoses different anomalies were noted such as conotruncal cardiac anomaly, velopharyngeal insufficiency, characteristic facial dysmorphic features, language impairment, developmental delay/learning difficulties, and immunologic anomalies or thymic hypoplasia. Laboratory studies included conventional cytogenetic and FISH testing. Metaphase and interphase cells were analyzed for the presence of 22q11.2 microdeletion or microduplication. There were 12 patients who carried 22q11.2 microdeletion and no microduplication in the region was identified. Other chromosomal anomalies were reported in five patients with an overlapped DG/VCFS phenotype. All patients with 22q11.2 microdeletion showed a characteristic phenotype of DG/VCFS. We did not identify 22q11.2 microduplication, suggesting that this is a rare event in patients with DG/VCFS features. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 17041934     DOI: 10.1002/ajmg.a.31499

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  16 in total

1.  Effect of copy number variants on outcomes for infants with single ventricle heart defects.

Authors:  Abigail S Carey; Li Liang; Jonathan Edwards; Tracy Brandt; Hui Mei; Andrew J Sharp; Daphne T Hsu; Jane W Newburger; Richard G Ohye; Wendy K Chung; Mark W Russell; Jill A Rosenfeld; Lisa G Shaffer; Michael K Parides; Lisa Edelmann; Bruce D Gelb
Journal:  Circ Cardiovasc Genet       Date:  2013-09-10

2.  Dysregulation of TBX1 dosage in the anterior heart field results in congenital heart disease resembling the 22q11.2 duplication syndrome.

Authors:  Erica Hasten; Donna M McDonald-McGinn; Terrence B Crowley; Elaine Zackai; Beverly S Emanuel; Bernice E Morrow; Silvia E Racedo
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

3.  Prenatal diagnosis of truncus arteriosus using multiplanar display in 4D ultrasonography.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Offer Erez; Sonia Hassan; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2010-04

4.  Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature.

Authors:  Fabíola P Monteiro; Társis P Vieira; Ilária C Sgardioli; Miriam C Molck; Ana Paula Damiano; Josiane Souza; Isabella L Monlleó; Marshall I B Fontes; Agnes C Fett-Conte; Têmis M Félix; Gabriela F Leal; Erlane M Ribeiro; Claudio E M Banzato; Clarissa de R Dantas; Iscia Lopes-Cendes; Vera Lúcia Gil-da-Silva-Lopes
Journal:  Eur J Pediatr       Date:  2013-02-26       Impact factor: 3.183

5.  Over-expression of a human chromosome 22q11.2 segment including TXNRD2, COMT and ARVCF developmentally affects incentive learning and working memory in mice.

Authors:  Go Suzuki; Kathryn M Harper; Takeshi Hiramoto; Birgit Funke; MoonSook Lee; Gina Kang; Mahalah Buell; Mark A Geyer; Raju Kucherlapati; Bernice Morrow; Pekka T Männistö; Soh Agatsuma; Noboru Hiroi
Journal:  Hum Mol Genet       Date:  2009-07-19       Impact factor: 6.150

6.  22q11.2 Deletion Syndrome: Laboratory Diagnosis and TBX1 and FGF8 Mutation Screening.

Authors:  Ilária C Sgardioli; Társis P Vieira; Milena Simioni; Fabíola P Monteiro; Vera L Gil-da-Silva-Lopes
Journal:  J Pediatr Genet       Date:  2015-03

Review 7.  Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders.

Authors:  N Hiroi; T Takahashi; A Hishimoto; T Izumi; S Boku; T Hiramoto
Journal:  Mol Psychiatry       Date:  2013-08-06       Impact factor: 15.992

Review 8.  The 22q11.2 Microdeletion in Pediatric Patients with Cleft Lip, Palate, or Both and Congenital Heart Disease: A Systematic Review.

Authors:  Diana Cárdenas-Nieto; Maribel Forero-Castro; Clara Esteban-Pérez; Julio Martínez-Lozano; Ignacio Briceño-Balcázar
Journal:  J Pediatr Genet       Date:  2019-10-23

9.  BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1.

Authors:  Anna Brunet; Lluís Armengol; Damià Heine; Jordi Rosell; Manel García-Aragonés; Elisabeth Gabau; Xavier Estivill; Miriam Guitart
Journal:  BMC Med Genet       Date:  2009-12-23       Impact factor: 2.103

Review 10.  A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review.

Authors:  Luis Fernández; Julián Nevado; Fernando Santos; Damià Heine-Suñer; Victor Martinez-Glez; Sixto García-Miñaur; Rebeca Palomo; Alicia Delicado; Isidora López Pajares; María Palomares; Luis García-Guereta; Eva Valverde; Federico Hawkins; Pablo Lapunzina
Journal:  BMC Med Genet       Date:  2009-06-02       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.